Chronotherapy of hypertension: Administration-time-dependent effects of treatment on the circadian pattern of blood pressure

被引:111
作者
Hermida, Ramon C.
Ayala, Diana E.
Calvo, Carlos
Portaluppi, Francesco
Smolensky, Michael H.
机构
[1] Univ Vigo, ETSI Telecommun, Bioengn & Chronobiol Labs, Vigo 36200, Pontevedra, Spain
[2] Hosp Clin Univ, Hypertens & Vasc Risk Unit, Santiago De Compostela 15706, Spain
[3] Univ Ferrara, Dept Clin & Expt Med, Hypertens Ctr, I-44100 Ferrara, Italy
[4] Univ Texas, Hlth Sci Ctr, Sch Publ Hlth, Houston, TX 77030 USA
关键词
Chronotherapy; chronopharmacodynamics; antihypertensive therapy; hypertension; dipper; non-dipper; blood pressure; circadian variation;
D O I
10.1016/j.addr.2006.09.021
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Some specific features of the 24-hour blood pressure (BP) pattern are linked to the progressive injury of target tissues and the triggering of cardiac and cerebrovascular events. Thus, there is growing interest in how to best tailor the treatment of hypertensive patients according to the circadian BP pattern of each individual. Significant administration-time differences in the kinetics (i.e., chronokinetics) plus beneficial and adverse effects (i.e., chronodynamics) of antihypertensive medications are well known. Thus, bedtime dosing with nifedipine GITS is more effective than morning dosing, while also significantly reducing adverse effects. The dose-response curve, therapeutic coverage, and efficacy of doxazosin GITS are all markedly dependent on the circadian time of drug administration. Moreover, valsartan administration at bedtime, as opposed to upon wakening, results in an improved diurnal/noctumal BP ratio, increased percentage of controlled patients, and significant reduction in urinary albumin excretion in hypertensive patients. Chronotherapy provides a means of individualizing the treatment of hypertension according to the circadian BP profile of each patient, and constitutes a new option to optimize BP control and to reduce the risk of cardiovascular disease (myocardial infarction and stroke) and of end-organ injury of the blood vessels and tissue of the heart, brain, kidney, eye, and other organs. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:923 / 939
页数:17
相关论文
共 125 条
[1]   The individual RDH index:: a novel vector index for statistical assessment of anti hypertensive treatment reduction, duration, and homogeneity [J].
Aboy, M ;
Fernández, JR ;
McNames, J ;
Hermida, RC .
BLOOD PRESSURE MONITORING, 2006, 11 (02) :69-78
[2]   Methodological considerations in the evaluation of the duration of action of anti hypertensive therapy using ambulatory blood pressure monitoring [J].
Aboy, M ;
Fernández, JR ;
Hermida, RC .
BLOOD PRESSURE MONITORING, 2005, 10 (03) :111-115
[3]   The population RDH index:: a novel vector index and graphical method for statistical assessment of anti hypertensive treatment reduction, duration, and homogeneity [J].
Aboy, Mateo ;
Fernández, José R. ;
Hermida, Ramón C. .
BLOOD PRESSURE MONITORING, 2006, 11 (03) :143-155
[4]  
[Anonymous], 2006, J HYPERTENS S4
[5]  
[Anonymous], CHRONOTHERAPEUTICS
[6]  
Ayala DE, 2006, J HYPERTENS, V24, pS86
[7]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[8]   CIRCADIAN-RHYTHM OF BLOOD-PRESSURE - INTERNAL AND EXTERNAL TIME TRIGGERS [J].
BAUMGART, P .
CHRONOBIOLOGY INTERNATIONAL, 1991, 8 (06) :444-450
[9]  
Belanger PM, 1997, HANDB EXP PHARM, V125, P177
[10]   DIURNAL-VARIATIONS OF BLOOD-PRESSURE AND MICROALBUMINURIA IN ESSENTIAL-HYPERTENSION [J].
BIANCHI, S ;
BIGAZZI, X ;
BALDARI, G ;
SGHERRI, G ;
CAMPESE, VM .
AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (01) :23-29